Ariel Messman-Rucker is an Oakland-born journalist who now calls the Pacific Northwest her home. When she’s not writing about politics and queer pop culture, she can be found reading, hiking, or ...

Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...

The Winter Olympics kick off this Friday in Northern Italy, and it will feature a single out trans athlete. Elis Lundholm, a freestyle mogul skier representing Sweden, will compete in the female ...

When Swedish skier Elis Lundholm first hits the slopes at the 2026 Winter Olympics next week, he will be making history. Lundholm is the first openly transgender athlete in the history of the winter ...

Aclamado cineasta não percebe como a escritora Suzanne Collins não foi levada a tribunal por plágio. O cineasta Quentin Tarantino está a revelar o seu Top 20 dos melhores filmes do século XXI no ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...

The booming market for weight-loss drugs has propelled Eli Lilly LLY-0.15%decrease; red down pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...

Eli Weaver was known as the Amish Stud on the social networking sites he used to meet women Alex Gurley is a contributing writer at PEOPLE. She has been working at PEOPLE since 2022. Her work has ...

Eli Lilly reported third-quarter earnings and revenue that topped estimates and hiked its full-year outlook, as the company continued to see strong demand for its blockbuster weight loss drug Zepbound ...

Cardi B has been embroiled in a $24 million lawsuit with security guard Emani Ellis since 2020. Ellis filed suit against Cardi (real name Belcalis Marlenis Almánzar) following an alleged altercation ...

Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...